Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis
- PMID: 1792690
- DOI: 10.1016/0165-6147(91)90637-8
Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis
Abstract
The vascular endothelium is a remarkably heterogeneous organ. In addition to well-characterized anatomical diversity in situ, specific differences are increasingly being recognized between surface antigens on endothelial cells from different tissues, including absence of the classic endothelial marker factor VIII-related antigen (von Willebrand factor) from many endothelial cells. Microvascular heterogeneity extends to properties of endothelial cells thought to be involved in tumour angiogenesis and metastasis, such as growth factor responsiveness and expression of cell adhesion molecules. These findings are not only of relevance to the unambiguous identification and characterization of cultured endothelial cells, but, as Roy Bicknell and colleagues discuss, may explain the phenomenon of preferential organ tumour metastasis and provide novel opportunities for antitumour therapy.
Similar articles
-
Adhesion molecules and their role in cancer metastasis.Cell Biophys. 1993 Aug-Dec;23(1-3):3-89. doi: 10.1007/BF02796507. Cell Biophys. 1993. PMID: 7895250 Review.
-
Cytokine-mediated tumor-endothelial cell interaction in metastasis.Curr Top Microbiol Immunol. 1996;213 ( Pt 2):13-30. doi: 10.1007/978-3-642-61109-4_2. Curr Top Microbiol Immunol. 1996. PMID: 9053288 Review. No abstract available.
-
Organ-derived microvessel endothelial cells exhibit differential responsiveness to thrombin and other growth factors.Microvasc Res. 1992 Jan;43(1):20-45. doi: 10.1016/0026-2862(92)90004-9. Microvasc Res. 1992. PMID: 1608338
-
Organ preference of metastasis. The role of organ-specifically modulated endothelial cells.Lab Invest. 1988 Apr;58(4):379-87. Lab Invest. 1988. PMID: 3357332
-
Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.Microcirculation. 2001 Oct;8(5):335-45. doi: 10.1038/sj/mn/7800098. Microcirculation. 2001. PMID: 11687945
Cited by
-
Therapeutic inhibition of angiogenesis.Mol Biotechnol. 2003 Oct;25(2):185-200. doi: 10.1385/MB:25:2:185. Mol Biotechnol. 2003. PMID: 14526126 Review.
-
A critical analysis of current in vitro and in vivo angiogenesis assays.Int J Exp Pathol. 2009 Jun;90(3):195-221. doi: 10.1111/j.1365-2613.2008.00633.x. Int J Exp Pathol. 2009. PMID: 19563606 Free PMC article. Review.
-
Tumor heterogeneity: preclinical models, emerging technologies, and future applications.Front Oncol. 2023 Apr 28;13:1164535. doi: 10.3389/fonc.2023.1164535. eCollection 2023. Front Oncol. 2023. PMID: 37188201 Free PMC article. Review.
-
Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.Breast Cancer Res Treat. 1994 Jan;29(1):109-16. doi: 10.1007/BF00666186. Breast Cancer Res Treat. 1994. PMID: 7517221
-
Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression.Am J Pathol. 1995 Aug;147(2):339-51. Am J Pathol. 1995. PMID: 7543733 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources